Breast Cancer Research and Treatment · 1998 · 145 citations · 33 references
MedicineOncologyPharmacologyCancer PharmacologyCarcinogenesisMetastasisBreast Cancer PharmacotherapyCholesterol BiosynthesisCholesterol MetabolismMammary TumorsMetastatic Breast CancerMetastatic Disease TreatmentCholesterol Biosynthesis ControlMetastatic Breast Cancer TreatmentMevalonate PathwayPharmacological Inhibition Of Cholesterol Biosynthesis
33
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Daniel E. Gómez, Daniel F. Alonso, Hitoshi Yoshiji et al. · PubMed · 1997 · 1.5K citations
p21ras is modified by a farnesyl isoprenoid.
Patrick J. Casey, Patricia A. Solski, Channing J. Der et al. · Proceedings of the National Academy of Sciences · 1989 · 855 citations · Full text
Phase I study of lovastatin, an inhibitor of the mevalonate pathway, in patients with cancer.
Alain Thibault, Dvorit Samid, A Tompkins et al. · PubMed · 1996 · 361 citations
Medicine, Oncology, Pharmacology +10